Transfusion-dependent

FDA approves first new gene therapy this year for rare blood disorder

The U.S. Food and Drug Administration has approved a new gene therapy for patients with transfusion-dependent beta-thalassemia, a rare inherited blood disorder that often requires frequent blood…